Cited by 101Clinical Laboratory Practices and Quality ControlHereditary Neurological DisordersPeripheral Neuropathies and Disorders

Contributors to Serum NfL Levels in People without Neurologic Disease

Open access
Fitzgerald, Kathryn C., Sotirchos, Elias S., Smith, Matthew D., Lord, Hannah‐Noelle, DuVal, Anna, Mowry, Ellen M., Calabresi, Peter A.·2022·Annals of Neurology

Abstract

Objective: To assess the effects of demographics, lifestyle factors, and comorbidities on serum neurofilament light chain (sNfL) levels in people without neurologic disease and establish demographic‐specific reference ranges of sNfL. Methods: The National Health and Nutrition Examination Survey (NHANES) is a representative sample of the US population in which detailed information on demographic, lifestyle, routine laboratory tests, and overall health status are systematically collected. From stored serum samples, we measured sNfL levels using a novel high‐throughput immunoassay (Siemens Healthineers). We evaluated the predictive capacity of 52 demographic, lifestyle, comorbidity, anthropometric, or laboratory characteristics in explaining variability in sNfL levels. Predictive performance was assessed using cross‐validated R 2 ( R 2 cv ) and forward selection was used to obtain a set of best predictors of sNfL levels. Adjusted reference ranges were derived incorporating characteristics using generalized additive models for location, scale, and shape. Results: We included 1,706 NHANES participants (average age: 43.6 ± 14.8 y; 50.6% male, 35% non‐white) without neurological disorders. In univariate models, age explained the most variability in sNfL ( R 2 cv = 26.8%). Multivariable prediction models for sNfL contained three covariates (in order of their selection): age, creatinine, and glycosylated hemoglobin (HbA1c) (standardized β—age: 0.46, 95% confidence interval [CI]: 0.43, 0.50; creatinine: 0.18, 95% CI: 0.13, 0.22; HbA1c: 0.09, 95% CI: 0.06, 0.11). Adjusted centile curves were derived incorporating identified predictors. We provide an interactive R Shiny application to translate our findings and allow other investigators to use the derived centile curves. Interpretation: Results will help to guide interpretation of sNfL levels as they relate to neurologic conditions. ANN NEUROL 2022;92:688–698

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.26446

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 25

  1. [1]Gaetani L, Blennow K, Calabresi P, Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry 2019; 90(8): 870– 881. 30967444
  2. [3]Khalil M, Teunissen CE, Otto M, Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 2018; 14(10): 577– 589. 30171200
  3. [4]Poesen K, De Schaepdryver M, Stubendorff B, Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology 2017; 88(24): 2302– 2309. 28500227
  4. [5]Ganesalingam J, An J, Shaw CE, Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem 2011; 117(3): 528– 537. 21418221 PMC3076545
  5. [6]Calabresi PA, Arnold DL, Sangurdekar D, Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring. Mult Scler 2021; 27(10): 1497– 1505. 33307998 PMC8414824
  6. [8]Uher T, Havrdova EK, Benkert P, Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis. Mult Scler 2021; 27(13): 2001– 2013. 34612753
  7. [9]Lin T-Y, Vitkova V, Asseyer S, Increased Serum Neurofilament Light and Thin Ganglion Cell-Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm 2021; 8(5): e1051. 34348969 PMC8362351
  8. [10]Maggi P, Kuhle J, Schädelin S, Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis. Neurology 2021; 97(6): e543– e553. 34088875 PMC8424501
  9. [11]Khalil M, Pirpamer L, Hofer E, Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun 2020; 11(1): 812. 32041951 PMC7010701
  10. [12]Koini M, Pirpamer L, Hofer E, Factors influencing serum neurofilament light chain levels in normal aging. Aging (Albany NY) 2021; 13(24):25729–25738 PMC8751593 34923481
  11. [13]Akamine S, Marutani N, Kanayama D, Renal function is associated with blood neurofilament light chain level in older adults. Sci Rep 2020; 10(1):20350. PMC7683708 33230211
  12. [14]Rosner B On the Detection of Many Outliers. Technometrics 1975; 17(2): 221– 227.
  13. [15]Lee S, Plavina T, Singh CM, Development of a highly sensitive neurofilament light chain assay on an automated immunoassay platform. medRxiv doi: 10.1101/2022.04.17.22273097 PMC9359312 35959400 · DOI
  14. [19]Cooper BG, Stocks J, Hall GL, The Global Lung Function Initiative (GLI) Network: bringing the world’s respiratory reference values together. Breathe (Sheff) 2017; 13(3): e56– e64. 28955406 PMC5607614
  15. [20]Quanjer PH, Hall GL, Stanojevic S, Age- and height-based prediction bias in spirometry reference equations. Eur Respir J 2012; 40(1): 190– 197. 22183491
  16. [21]Hall GL, Filipow N, Ruppel G, Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry. Eur Respir J 2021; 57(3) 33707167
  17. [22]Yilmaz A, Blennow K, Hagberg L, Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls. Expert Rev Mol Diagn 2017; 17(8): 761– 770. 28598205
  18. [23]Benkert P, Meier S, Schaedelin S, Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol 2022; 21(3): 246– 257. 35182510
  19. [24]Polymeris A, Helfenstein F, Benkert P, Renal function and body mass index contribute to serum neurofilament light chain levels in elderly patients with atrial fibrillation. Frontiers in Neuroscience 2022; 16:819010. PMC9047720 35495025
  20. [25]Calabresi PA, Austin H, Racke MK, Impaired renal function in progressive multiple sclerosis. Neurology 2002; 59(11): 1799– 1801. 12473777
  21. [27]Korley FK, Goldstick J, Mastali M, Serum Neurofilament Light Chain Levels and Incident Stroke In Adults with Diabetes. Stroke 2019; 50(7): 1669– 1675. 31138085 PMC6591022
  22. [28]O’Bryant S, Petersen M, Hall J, Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study. Alzheimer’s & Dementia 2022; 18(2): 240– 250 PMC9228481 34310015
  23. [29]Marques A, Peralta M, Naia A, Prevalence of adult overweight and obesity in 20 European countries, 2014. European Journal of Public Health 2018; 28(2): 295– 300. 29036436
  24. [30]Manouchehrinia A, Piehl F, Hillert J, Confounding effect of blood volume and body mass index on blood neurofilament light chain levels. Ann Clin Transl Neurol 2020; 7(1): 139– 143. 31893563 PMC6952306
  25. [31]Beydoun MA, Noren Hooten N, Maldonado AI, BMI and allostatic load are directly associated with longitudinal increase in plasma neurofilament light among urban middle-aged adults. The Journal of Nutrition 2021;nxab381. PMC8826916 34718678

Cited by

Sorted by citations

Authors
Fitzgerald, K. C., Sotirchos, E. S., Smith, M. D., Lord, H., DuVal, A., Mowry, E. M., & Calabresi, P. A.
Affiliations
Johns Hopkins University (US)
Corresponding author
  • Fitzgerald, Kathryn C.
  • Calabresi, Peter A.
Venue
Annals of Neurology
Publisher
Wiley
Published
2022-07-13
Volume
92
Issue
4
Pages
688-698
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W4283328517
Cited by
101
References
4
Citations by year
2026: 15 · 2025: 27 · 2024: 36 · 2023: 18 · 2022: 5
Type
paratext
Language
en
Open access
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Mental Health (1K01MH121582‐01)
  • National Institute of Neurological Disorders and Stroke (5K23NS117883‐02, U01NS111678)
  • National Multiple Sclerosis Society (RG‐1904‐33800, TA‐1805‐31136)
Topics
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
Keywords
serum neurofilament light chain, reference values, healthy population, age, creatinine, HbA1c, comorbidities, lifestyle factors, centile curves, NHANES
MeSH terms
Adult, Creatinine, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Nervous System Diseases, Nutrition Surveys, Biomarkers, Neurofilament Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review